Antiviral activity of 2-chloro-2'-deoxyadenosine (2-CdA)

Area of Science:

• Virology
• Molecular Biology
• Pharmacology

Background:

• Herpes simplex virus type 1 (HSV) is a common human pathogen.
• Antiviral therapies are crucial for managing HSV infections.
• Understanding drug mechanisms of action is key to developing effective treatments.

Purpose of the Study:

• To evaluate the antiviral effect of 2-chloro-2 eal-deoxyadenosine (cladribine, 2-CdA) against HSV-1 replication.
• To compare the efficacy of 2-CdA with acyclovir, a known anti-HSV drug.
• To investigate the mechanism of action of 2-CdA in HSV-infected cells.

Main Methods:

• Vero cells were infected with HSV-1 and treated with varying concentrations of 2-CdA and acyclovir.
• Cytotoxicity assays were performed to determine non-toxic drug concentrations.
• Antiviral efficacy was assessed by calculating ED50 and ED100 values.
• DNA cell cytometry was used to analyze the effect of 2-CdA on the cell cycle.

Main Results:

• 2-CdA was not cytotoxic to Vero cells up to 600 micrograms/ml.
• The ED50 and ED100 for 2-CdA were approximately 5 and 70 micrograms/ml, respectively.
• Acyclovir showed higher potency with ED50 and ED100 values of 0.16 and 1.6 micrograms/ml.
• 2-CdA induced a progressive S-phase block in DNA cell cytometry at concentrations of 0.14 microgram/ml and higher.

Conclusions:

• 2-CdA exhibits a weak antiviral effect against HSV-1, primarily through interference with host cell DNA replication.
• The drug is likely activated by host cell kinases, not by HSV-encoded thymidine kinase.
• 2-CdA's mechanism differs from acyclovir, suggesting potential for combination therapies or alternative applications.